EP Patent

EP2132211A4 — 4-cyanophenylamino-substituted bicyclic heterocyclic compounds as hiv inhibitors

Assigned to Ardea Biociences Inc · Expires 2011-12-07 · 14y expired

What this patent protects

Patent listed against naftifine-hydrochloride.

Drugs covered by this patent

naftifine-hydrochloride (NAFTIFINE HYDROCHLORIDE)

Patent Metadata

Patent number: EP2132211A4
Jurisdiction: EP
Classification: —
Expires: 2011-12-07
Drug substance claim: No
Drug product claim: No
Assignee: Ardea Biociences Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.